Back to all Programs

Past Event

Related Materials

Past Event

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015

Penetration of rifampin and rifapentine into diseased lung in the rabbit cavity pulmonary disease model of TB - D. Rifat

Clofazimine: Current Status and Future Prospects - Eric Nuermberger, MD

Population pharmacokinetics and penetration of first and second line anti-TB drugs in pulmonary lesions from adults with active tuberculosis - S. Gupta

04_Denti

The Pharmacokinetics/Pharmacodynamics of Delamanid - Suresh Mallikaarjun, PhD, FCP

Pharmacokinetics and pharmacodynamics of pyrazinoic acid in murine models of tuberculosis - J. Lanoix

Pharmacodynamics of sulfamethoxazole in in vitro and in vivo models of tuberculosis - E. Nuermberger

Contribution of different oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in murine models of tuberculosis - R. Tasneen

Pharmacokinetics of rifampicin and moxifloxacin in the PanACEA-MAMS-TB-01 trial - R. Aarnoutse

The Systems Pharmacology Approach to Improve TB Treatment - Rada Savic, PharmD, PhD

Concentration-response effects of combination therapy in a murine model of tuberculosis: optimizing the dosing regimen for short-course therapy - N. Zhang

12_Wiltshire

Dose optimization for combinations of three or more drugs: an application to dose selection in regimen-based tuberculosis drug development - M. Lyons

Mathematical model of drug-target binding predicts optimal antibiotic treatment - P. Abel zur Wiesch

TB and Diabetes Mellitus: Pharmacological Aspects of the Convergence of Two Epidemics - Rovina Ruslami, MD, PhD

Digitizing MTB Medicines: Using compounding methods to enable mobile capture of MTB medication adherence - S. Browne

Prediction of drug partitioning into tubercular pulmonary lesions - C. Chen

Drug Partitioning and Local Microenvironmental Conditions affect Bedaquiline, Clofazimine and Pyrazinamide Treatment Responses in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice - S. Irwin

Quantitative modeling of time to positivity following dosing of bedaquiline and rifafour in patients with pulmonary tuberculosis infection - J.F. Marier